Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Alice Markussen,Julia S. Johansen,Finn Ole Larsen,Susann Theile,Jane Preuss Hasselby,Gro Linno Willemoe,Torben Lorentzen,Kasper Madsen,Estrid Høgdall,Tim Svenstrup Poulsen,Eva E. Wilken,Poul Geertsen,C.F. Behrens,Inge Marie Svane,Dorte Nielsen,Inna M. Chen
出处
期刊：Clinical Cancer Research [American Association for Cancer Research] 日期：2024-06-14卷期号：30 (16): 3428-3437被引量：1
The purpose of this study was to evaluate the clinical benefits of nivolumab with/without ipilimumab combined with stereotactic body radiotherapy (SBRT) in patients with pretreated metastatic biliary tract cancer (mBTC).
爱静静
浦肯野
紫色水晶之恋
JZX
sutharsons
pcr163
VDC
mmyhn
tuanheqi
Qi
小红薯7XJ9B2Q4
ceeray23
morena
美好斓
Tania
樱桃猴子
白桦
Hayat
SYLH
neu_zxy1991
皖公网安备34019202002308
